Charles River Associates (CRA) Names Patrick Hillan Vice President, Expanding Life Sciences Commercial Strategy Expertise
Business Wire•29/09/2026•08:30 ET
0
Key Highlights
- ➤Patrick Hillan named Vice President in CRA’s (CRAI) Life Sciences Practice
- ➤Hillan brings medical affairs strategy and launch-readiness expertise
- ➤CRA says appointment will scale life sciences advisory services
- ➤Hillan previously partnered with pharmaceutical and biotechnology companies across therapeutic areas
Expert Statements
Paul Maleh, President and Chief Executive Officer of Charles River Associates
“I am happy to welcome Patrick to CRA. He has deep expertise in medical affairs strategy, having partnered with global pharmaceutical and biotechnology companies across a broad range of therapeutic areas to generate actionable stakeholder insights, develop evidence-based strategies, and support successful product launches worldwide.”
Dr. Gregory K. Bell, CRA Group Vice President and Life Sciences Practice Leader
“Patrick’s expertise in medical affairs will be instrumental as we continue to enhance and scale our life sciences advisory services. His ability to translate stakeholder insights, scientific evidence, and evolving market dynamics into actionable medical strategies will strengthen the support we provide to medical affairs teams, while helping clients make informed decisions to support successful launches, and maximize the value of their innovations.”
Charles River Associates (CRA) Names Patrick Hillan Vice President, Expanding Life Sciences Commercial Strategy Expertise
Charles River Associates (NASDAQ: CRAI), a worldwide leader in providing economic, financial, and management consulting services , today announced the addition of Patrick Hillan as a Vice President in the firm’s Life Sciences Practice .
Get started
Create a free account to read the full story.